PASSAGE BIO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure.

Passage Bio, Inc. (the "Company") will present at the J.P Morgan 39th Annual Healthcare Conference being held virtually on Monday, January 11, 2021 at 7:30am ET. Additionally, on January 11, 2021, the Company issued a press release regarding its corporate outlook detailing the expansion of the Company's pipeline, new regulatory filings, projected program milestones, and research and development progress.

A copy of the press release and corporate presentation are attached as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form 8-K.

The information furnished with this report, including Exhibits 99.1 and 99.2, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Exchange Act or the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



Exhibit No.                Description
  99.1          Press Release by Passage Bio, Inc.
  99.2          Corporate Presentation.




                                       2

© Edgar Online, source Glimpses